Joan M O'Neal

Title: Joan M O'Neal: Innovator in Pharmaceutical Chemistry

Introduction

Joan M O'Neal is a distinguished inventor based in Glendale, MO (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target hypertension and cardiovascular health. With a total of 3 patents to her name, O'Neal's work has had a profound impact on medical science.

Latest Patents

O'Neal's latest patents include innovative compounds such as cycloheptimidazolone compounds, which serve as angiotensin II antagonists for controlling hypertension. These compounds are characterized by a specific formula that allows for various substitutions, making them versatile in their application. Another notable patent involves the synthesis and use of linear free-sulfhydryl-containing oligopeptide derivatives. These novel oligopeptides exhibit a high affinity for the Atrial Natriuretic Peptide (ANP) receptor, demonstrating their potential to lower blood pressure in mammals.

Career Highlights

Throughout her career, Joan M O'Neal has been associated with G.D. Searle & Company, where she has played a pivotal role in advancing pharmaceutical research. Her innovative approach to drug development has positioned her as a key figure in her field.

Collaborations

O'Neal has collaborated with notable colleagues such as Philippe R Bovy and Timothy S Chamberlain. These partnerships have further enriched her research and contributed to the success of her inventions.

Conclusion

Joan M O'Neal's contributions to pharmaceutical chemistry exemplify her dedication to innovation and improving healthcare outcomes. Her patents reflect a commitment to advancing medical science and addressing critical health issues.